Our blog: China’s technology, consumer and new retail insights
We’ve written a lot of articles on a variety of topics that can benefit everyone from a complete beginner to experienced marketers. Do a search for a specific topic of interest or read them in sequence for a broader view. It’s up to you.
LATEST CHINA MARKETING AND CONSUMERS INSIGHTS
Tiangong Space Station: China’s Orbital Research Platform
China’s Space Station, Tiangong, is a permanently inhabited orbital laboratory that supports scientific experiments, technology testing, and long-duration crewed spaceflight. Its three connected modules give China a research platform that requires sustained access to microgravity. The Chinese Tiangong space station matters beyond aerospace. Recent semiconductor and battery studies address questions relevant to electronics and energy […]
Zai Lab: Building a Cross-Border Biopharma Pipeline
Zai Lab is a commercial-stage biopharmaceutical company operating across China and the United States. Its model combines regional licensing and commercialization with global drug development through partnerships and internal discovery. Its therapeutic priorities include oncology, immunology, neuroscience, and infectious disease. Its 2026 strategy update explains this combination of a regional business and global research programs. […]
International Lunar Research Station: China’s Moon Base Plan
The International Lunar Research Station (ILRS) is a China-led plan for a scientific facility on the Moon’s surface and in lunar orbit. China targets a basic station near the lunar south pole by 2035. Its proposed operating model combines long periods of autonomous activity with short human visits, according to chief designer Wu Weiren’s 2025 […]
RayNeo: TCL’s Smart-Glasses Bet and China’s AR Hardware Push
RayNeo is a smart-glasses company incubated within TCL Electronics. Its products span wearable entertainment screens, camera-free AI glasses, and full-color augmented reality devices. The company matters because it connects display engineering with practical questions about software, distribution, and everyday use. These specific choices make China’s AR progress easier to assess. A portable cinema, a discreet […]
3SBio: Biologics Scale and China’s Licensing Model
3SBio is a Chinese biopharmaceutical company that combines commercial biologics, antibody development, and international licensing. Its 2025 agreement with Pfizer connects a China-developed cancer drug candidate, SSGJ-707, with a multinational partner’s development and commercialization capabilities. The transaction illustrates how Chinese biomedical innovation can reach global markets through negotiated partnerships. The commercial story extends beyond the […]
Vision-Language-Action Models: How Physical AI Learns to Act
Vision-Language-Action Models turn visual observations and language instructions into robot actions. They learn from examples that connect what a robot sees, the requested task, and the movements needed to complete it. Unlike a model that describes a scene, a VLA predicts physical commands. Their commercial promise is flexible automation across changing products and settings. The […]
XtalPi: AI, Robotics and the Rise of Autonomous Drug R&D
XtalPi is a Shenzhen-based research technology company that combines AI, physics-based modeling, and laboratory robotics to discover and develop drug candidates. Its approach links digital predictions with physical experiments, letting results inform the next research cycle. The business sells discovery services and laboratory infrastructure while developing assets for licensing. That combination makes it a useful […]
Moore Threads: China’s Full-Stack GPU Bet for AI Computer
Moore Threads is a Chinese GPU designer building a full-stack GPU platform for AI training, inference, graphics, and scientific computing. Its offering combines GPU hardware with MUSA software and KUAE computing systems. The business significance lies in the package: companies evaluating China’s domestic compute need to assess the applications, engineering work, and service reliability around […]
Innovent Biologics: Building China’s Innovative Drug Platform
Innovent Biologics is a China-based biopharmaceutical company that discovers, develops, manufactures, and sells medicines. Its portfolio spans oncology, metabolic disease, autoimmune disease, and eye conditions, combining marketed treatments with experimental programs and international partnerships. An October 2026 company update reported 20 launched products. The company matters because it offers a concrete example of China’s expanding […]
Robot Datasets: How China Is Training Embodied AI at Scale
Robot datasets record what machines observe, the actions they take, and the outcomes that follow. China is expanding this resource through teleoperation facilities, published real-machine data collections, and simulation. These systems train embodied AI, which learns to act in physical environments. The business question is how that data translates into reliable work. China’s recent projects […]
Chang Guang Satellite: Jilin-1 and China’s Imaging Network
Chang Guang Satellite is the Changchun-based company behind the Jilin-1 constellation, a Chinese commercial Earth observation network. It develops satellites and supplies imagery and related information services. Xinhua reported in September 2026 that the company had launched 161 satellites for the network. Its business relevance spans crop monitoring, mapping, and automated image analysis. The company […]
Asymchem: How China’s CDMO Model Scales Drug Manufacturing
Asymchem is a China-based CDMO (contract development and manufacturing organization) that develops production processes and manufactures drug ingredients and finished products for pharmaceutical companies. Its model connects process research with specialized equipment, quality controls, and commercial supply. Recent disclosures point to three key developments: larger peptide facilities, Chinese-developed equipment operating in the UK, and closer […]